MI efficiently inhibits bladder cancer progression both in vitro and in vivo by inhibiting the Nox4/NF-κB/HIF-1α signaling pathway by directly upregulating miR-26b expression, suggesting that MI might be a potential anticancer agent for bladder cancer. The gene discussed is NFKB1; the disease is urinary bladder cancer.